Iovance Biotherapeutics Ownership | Who Owns Iovance Biotherapeutics?
Iovance Biotherapeutics Ownership Summary
Iovance Biotherapeutics is owned by 77.29% institutional investors, 0.53% insiders, and 22.19% retail investors. Vanguard group is the largest institutional shareholder, holding 9.75% of IOVA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.82% of its assets in Iovance Biotherapeutics shares.
IOVA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Iovance Biotherapeutics | 77.29% | 0.53% | 22.19% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 25.95M | 9.75% | $208.12M |
| Perceptive advisors | 25.93M | 9.74% | $207.98M |
| Mhr fund management | 24.00M | 9.01% | $192.46M |
| Blackrock | 21.23M | 7.97% | $170.23M |
| State street | 12.63M | 4.74% | $101.25M |
| Avoro capital advisors | 11.70M | 4.39% | $93.83M |
| Soleus capital management | 7.55M | 2.84% | $60.53M |
| Geode capital management | 5.79M | 2.17% | $46.42M |
| Artisan partners limited partnership | 5.11M | 1.92% | $40.99M |
| Balyasny asset management | 4.54M | 1.71% | $36.42M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mhr fund management | 24.00M | 23.45% | $192.46M |
| Soleus capital management | 7.55M | 5.34% | $60.53M |
| Perceptive advisors | 25.93M | 4.94% | $207.98M |
| Bioimpact capital | 2.37M | 2.95% | $18.98M |
| Parametrica management | 261.09K | 2.77% | $2.09M |
| Orion investment | 794.70K | 2.54% | $6.37M |
| Palo alto investors lp | 2.12M | 1.97% | $16.97M |
| Cm management | 250.00K | 1.84% | $2.00M |
| Long focus capital management | 4.13M | 1.27% | $33.14M |
| Avoro capital advisors | 11.70M | 1.25% | $93.83M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Perceptive advisors | 25.93M | 4.94% | 6.66M |
| Soleus capital management | 7.55M | 5.34% | 4.04M |
| Balyasny asset management | 4.54M | 0.06% | 3.34M |
| Long focus capital management | 4.13M | 1.27% | 2.73M |
| State street | 12.63M | 0.00% | 2.22M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Pictet asset management sa | 920.08K | 0.01% | -2.33M |
| Price t rowe associates inc /md/ | 3.48M | 0.00% | -1.79M |
| Marshall wace, llp | - | - | -1.61M |
| Summit partners public asset management | - | - | -1.56M |
| Woodline partners lp | - | - | -1.48M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Assenagon asset management | 1.75M | 0.02% | 1.75M | $12.93M |
| Artal group | 1.01M | 0.21% | 1.01M | $8.11M |
| Norges bank | 942.98K | 0.00% | 942.98K | $7.56M |
| Orion investment | 794.70K | 2.54% | 794.70K | $6.37M |
| Two sigma investments, lp | 774.78K | 0.01% | 774.78K | $6.21M |
Sold Out
| Holder | Change |
|---|---|
| Massmutual trust co fsb/adv | -28.00 |
| Cibc private wealth group | -35.00 |
| Nelson, van denburg & campbell wealth management group | -46.00 |
| Fifth third bancorp | -62.00 |
| Cva family office | -63.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 292 | -5.19% | 234,393,808 | 0.82% | 77 | 1.01% | 149 | -17.22% | 80 | -2.44% |
| Jun 30, 2024 | 305 | 2.69% | 232,471,450 | 7.59% | 87 | 1.23% | 177 | 9.94% | 82 | -6.82% |
| Mar 31, 2024 | 297 | 18.33% | 216,063,214 | 4.25% | 84 | 1.19% | 161 | 13.38% | 88 | 31.34% |
| Dec 31, 2023 | 251 | 1.21% | 207,248,234 | -2.24% | 84 | 0.95% | 142 | -2.74% | 67 | 21.82% |
| Sep 30, 2023 | 248 | 7.83% | 212,001,334 | 3.96% | 94 | 1.04% | 146 | 18.70% | 55 | -15.38% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 8.61M | 2.82% | 10.61K |
| iShares Russell 2000 ETF | 7.35M | 2.41% | -28.25K |
| Vanguard Small Cap Index | 6.99M | 2.29% | 100.08K |
| SPDR® S&P Biotech ETF | 6.31M | 2.07% | -73.75K |
| Vanguard Small Cap Value Index Inv | 4.64M | 1.52% | -14.21K |
| Hood River Small-Cap Growth Instl | 4.58M | 1.50% | 3.17M |
| Vanguard Institutional Extnd Mkt Idx Tr | 3.45M | 1.13% | 72.89K |
| Macquarie Small Cap Core I | 2.94M | 0.96% | 328.85K |
| Delaware Small Cap Core I | 2.61M | 0.86% | 1.84M |
| Fidelity Small Cap Index | 2.59M | 0.85% | 10.17K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 12, 2024 | Maynard Ryan D | - | Sell | $503.00K |
| Feb 20, 2024 | MCPEAK MERRILL A | - | Buy | $2.29M |
| Feb 20, 2024 | Dukes Iain D. | - | Buy | $292.80K |
| Feb 20, 2024 | Rothbaum Wayne P. | - | Buy | $45.75M |
| Sep 18, 2023 | MCPEAK MERRILL A | - | Buy | $55.60K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 1 |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | 3 | - |
| 2023 Q4 | - | - |
IOVA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools